Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
NCT ID: NCT02888197
Last Updated: 2018-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
32 participants
OBSERVATIONAL
2016-08-16
2017-03-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
NCT02733432
A Study of Oral Oteseconazole (VT-1161) for the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT03561701
Vulvovaginal Candidiasis in Canadian Females
NCT04930107
A Clinical Study Intended To Compare Treatment With Voriconazole To Treatment With Amphotericin Followed By Fluconazole In Patients With Candidemia, A Serious Fungus Infection Of The Blood.
NCT00163111
A Study to Evaluate Oral VT-1161 in the Treatment of Patients With Recurrent Vaginal Candidiasis (Yeast Infection)
NCT02267382
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Received at least one dose of study drug in the primary study
* Able to give written informed consent prior to completion of the primary study
Exclusion Criteria
* Diagnosed with bacterial vaginosis, trichomonas, gonorrhea, chlamydia, or active herpes at any point during the primary study
* The Principal Investigator considers that the subject should not participate in the study
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cidara Therapeutics Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alena Jandourek, MD
Role: STUDY_DIRECTOR
Cidara Therapeutics
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Precision Trials AZ
Phoenix, Arizona, United States
The Women's Clinical, P.A.
Little Rock, Arkansas, United States
Women's Health Care Research Corp
San Diego, California, United States
Olympian Clinical Research
Clearwater, Florida, United States
Women's Medical Research
Clearwater, Florida, United States
Altus Research Inc
Lake Worth, Florida, United States
New Age Medical Research Corporation
Miami, Florida, United States
Augusta University
Augusta, Georgia, United States
Clinical Trials Management LLC
Metairie, Louisiana, United States
Wayne State University
Detroit, Michigan, United States
Saginaw Valley Medical Research Group LLC
Saginaw, Michigan, United States
Lawrence OB GYN Clinical Research LLC
Lawrenceville, New Jersey, United States
Alliance Women's Research Group LLC
Riverside Park, New Jersey, United States
Soffolk OB/GYN
Port Jefferson, New York, United States
Eastern Carolina Women's Center
New Bern, North Carolina, United States
Hawthorne Medical Research Inc
Winston-Salem, North Carolina, United States
Unified Women's Clinical Research - Hickory
Winston-Salem, North Carolina, United States
Women's Health Research
Columbus, Ohio, United States
Drexel University
Philadelphia, Pennsylvania, United States
TMC Life Research Inc.
Houston, Texas, United States
Clinical Trials of Texas Inc
San Antonio, Texas, United States
Tidwewater Physicians for Women
Norfolk, Virginia, United States
Seattle Women's Health, Research, Gynecology
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CD101.TP.2.02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.